Oncology medical news

Headlines

20 Oct 2018 - Oncology Conference reports ESMO 2018 – Synthetic peptides hit three targets simultaneously in recurrent glioblastoma
Updated phase II data for the novel immunotherapeutic (SL-701) show “preliminarily promising survival curve” with good tolerability
20 Oct 2018 - Oncology Conference reports ESMO 2018 – Adding ribociclib to fulvestrant maintains quality of life in advanced breast cancer
Health-related quality of life (HRQoL) outcomes from the MONALEESA-3 trial demonstrate that patients don’t have to suffer more to achieve prolonged progression-free survival.
20 Oct 2018 - Oncology Conference reports ESMO 2018 - Tepotinib+gefitinib, a promising combination therapy in MET+/EGFR-mutant non-small cell lung cancer
Data from a phase 2 study showed encouraging efficacy and safety results for a new combination regimen in patients with advanced MET+NSCLC

Latest Updates

20 Oct 2018 - Oncology Conference reports ESMO 2018 – One in six premenopausal breast cancer patients inadequately adherent to tamoxifen after one year
French study is the first to assess adherence using serum tamoxifen levels rather than self-declaration
20 Oct 2018 - Oncology Conference reports ESMO 2018 – Adding radium-223 to abiraterone associated with poorer outcomes in mCRPC
Trial reports more fractures and more deaths in patients given radium-223 in addition to abiraterone
19 Oct 2018 - UK Medical News Influence of sex on chemo toxicity in oesophagogastric cancer
A pooled analysis of 4 randomised controlled trials involving 1654 patients.
19 Oct 2018 - Oncology Clinical Digest from Cancer Advanced melanoma: adding ziv-aflibercept to IL-2 boosts PFS
Phase 2 data support use of VEGF inhibitors to enhance IL-2 benefit.
19 Oct 2018 - Oncology Clinical Digest from Leukemia R/R CLL/SLL: updated results for the phase 3 HELIOS study
Results at nearly 3 years of follow-up.
19 Oct 2018 - Oncology Clinical Digest from Lancet Oncol Postmastectomy RT: chest wall symptoms affect QoL in UK SUPREMO
Effect was small, and no other symptoms affected QoL at 2 years.
19 Oct 2018 - Oncology Clinical Digest from Eur Urol Bladder cancer: no survival advantage for extended vs limited LND in German study
Data from a randomized phase 3 trial.
19 Oct 2018 - Oncology Clinical Digest from JAMA Intern Med CRC screening boosted with FBT outreach, patient navigators
Meta-analysis of 73 RCTs identifies optimal intervention.
19 Oct 2018 - Oncology Clinical Digest from PLoS One Lung cancer surgery: lymphopenia on postoperative day 1 tied to POP
Postoperative pneumonia occurs in up to 25% of patients.
19 Oct 2018 - International Clinical Digest from Am J Gastroenterol IBD tied to risks for lymphoma, biliary cancer — but not CRC
5-ASA and biologics were protective against malignancy.
19 Oct 2018 - Oncology Clinical Digest from Lancet Oncol 3D screening mammography detects 34% more breast cancers
MALMO trial shows higher sensitivity, slightly lower specificity vs traditional mammography.
19 Oct 2018 - International Clinical Digest from J Clin Endocrinol Metab Thyroid ultrasound tied to increased diagnosis of low-risk cancer
Thyroid cancer may be overdiagnosed and overtreated.
18 Oct 2018 - Oncology news from BMJ Review of cardiovascular risk with tamoxifen vs aromatase inhibitors
Meta-analysis of risk differences for thromboembolism, myocardial infarction, angina, stroke, heart failure, and arrhythmia.
18 Oct 2018 - Oncology news from Leukemia Chronic lymphocytic leukaemia: long-term data from the HELIOS trial
The long-term data support improved survival with ibrutinib with bendamustine and rituximab in relapsed chronic lymphocytic leukaemia/small lymphocytic lymphoma

Related topics

You're leaving Univadis